Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies
AssigneeF-Star Biotechnologische Forschungs-Und Entwicklungsges. M.B.H.
InventorsGeert Mudde, Gottfried Himmler
Life of this patent
Estimating the term…
Abstract
A molecule or molecule complex capable of binding to TLR9 and to CD32 comprising at least one epitope of at least one antigen, its production and its use a medicament, especially for the treatment of allergies.
Claims26
A molecule or molecule complex comprising a TLR9 binding region capable of binding to TLR9, a CD32 binding region capable of binding to CD32, and at least one epitope of at least one antigen.
(canceled)
(canceled)
18-20. (canceled)
(canceled)
A nucleic acid comprising a nucleic acid sequence selected from the group consisting of SEQ ID No 60, SEQ ID No 62, SEQ ID No 63, and SEQ ID No 64.
27-29. (canceled)
Dependencies are inferred from the claim text.